Puma Biotechnology Inc (0PB.BE)

Berlin - Berlin Delayed price. Currency in EUR

Add to watchlist

2.7180

-0.0700

(-2.51%)

At close: 08:21PM CEST

Loading interactive chart…

Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
LOS ANGELES, July 02, 2024--Puma Biotechnology granted an inducement award to one new employee, who was hired in June 2024.
Business Wire
Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer
LOS ANGELES, June 03, 2024--Puma Biotechnology Announced Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer at the 2024 ASCO Annual Meeting.
Business Wire
Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)
LOS ANGELES, June 02, 2024--Puma Biotechnology announced that findings from the Phase II trial of its drug alisertib (TBCRC 041) were presented at the ASCO 2024 Annual Meeting.